-
-
-
-
-
-
-
Pfizer (PFE) Completes Acquisition of Global Blood Therapeutics (GBT)
-
-
-
-
-
-
-
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
-
-
-
-
-
-
-
Guerbet: 2021 half-year results
-
-
-
-
-
-
-
SS&C Technologies (SSNC) Enters Non-Binding Indicative Proposal to Acquire GBST
-
-
-
-
-
-
-
Guerbet: 2018 annual results
-
-
-
-
-
-
-
Pre-Open Movers 12/03: (TSRO) (GBT) (NBEV) Higher; (OCUL) (BLUE) (GSK) Lower (more...)
-
-
-
-
-
-
-
Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

